Bank of Montreal’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q2 | – | Sell |
-4
| Closed | – | – | 4487 |
|
2020
Q1 | $0 | Sell |
4
-4,373
| -100% | – | ﹤0.01% | 4415 |
|
2019
Q4 | $205K | Buy |
4,377
+1,325
| +43% | +$62.1K | ﹤0.01% | 2674 |
|
2019
Q3 | $72K | Sell |
3,052
-780
| -20% | -$18.4K | ﹤0.01% | 2984 |
|
2019
Q2 | $115K | Buy |
3,832
+2,627
| +218% | +$78.8K | ﹤0.01% | 2818 |
|
2019
Q1 | $27K | Sell |
1,205
-190
| -14% | -$4.26K | ﹤0.01% | 3173 |
|
2018
Q4 | $26K | Buy |
1,395
+93
| +7% | +$1.73K | ﹤0.01% | 3212 |
|
2018
Q3 | $24K | Buy |
1,302
+6
| +0.5% | +$111 | ﹤0.01% | 3337 |
|
2018
Q2 | $13K | Buy |
1,296
+296
| +30% | +$2.97K | ﹤0.01% | 3561 |
|
2018
Q1 | $5K | Buy |
1,000
+980
| +4,900% | +$4.9K | ﹤0.01% | 3644 |
|
2017
Q4 | $0 | Buy |
+20
| New | – | ﹤0.01% | 3994 |
|
2017
Q1 | – | Sell |
-23
| Closed | – | – | 3854 |
|
2016
Q4 | $0 | Buy |
+23
| New | – | ﹤0.01% | 3862 |
|